We report on five clinical isolates routinely identified as Candida lusitaniae that the ID 32C system was unable to discriminate from the closely related species Candida pulcherrima. When additional tests did not allow accurate identification, the less usual mating type test identified all of them as Clavispora lusitaniae.Mating type testing appears to be a valuable tool for assessing the true incidence of this emerging non-albicans Candida species.The variety of non-albicans Candida species involved in human pathology, their rising contribution to invasive infections, and the unusual antifungal susceptibility profiles of some of these species make their identification to the species level essential for epidemiological investigations and for optimizing therapy and patient management (8). In clinical laboratories, routine identification is usually performed with commercial systems that have more or less broad databases and that often combine classical phenotypic tests, i.e., assimilation, biochemical, and morphology tests. However, as these phenotypic characteristics may be variable, these methods may fail to discriminate between closely related species, leading to false or doubtful identifications, and may fail to detect new emergent pathogens (3, 6, 7). Candida lusitaniae, which is characterized by its propensity to develop resistance to amphotericin B during therapy, belongs to this important group of opportunistic pathogens (1, 4). Interestingly, it is one of the opportunistic Candida species that have a known sexual cycle (4). Its teleomorph, Clavispora lusitaniae, is a heterothallic ascomycetous yeast from the Metschnikowiaceae family (11). A mating type test has thus been developed to unambiguously identify C. lusitaniae isolates (2).We report on five clinical isolates that the ID 32C system (bioMérieux, Marcy l'Etoile, France) suggested were either C. lusitaniae or Candida pulcherrima, another member of the Metschnikowiaceae family, which is a potential pathogen (4). These isolates were definitely identified as Clavispora lusitaniae through mating tests.The five clinical isolates were obtained from five patients hospitalized in four medical centers by partner clinical laboratories. They were recovered from stool (isolates 74 and 147), the upper respiratory tract (isolate 87), and blood (isolates 93 and 155). They were presumptively identified as C. lusitaniae by routine testing. Before they were added to our collection, their identities were checked with the ID 32C system. The test was performed in accordance with the manufacturer's instructions. Growth in each well was determined by visual reading after 48 h of incubation. Results were recorded as a 10-digit numerical profile (biocode), which was analyzed by the API Lab software (bioMérieux). Depending on the results, identification can be made to the species or genus level or can be considered unreliable. The results were given as an identification percentage (%id) that represents the relative proximity of the profile obtained for the taxon to those of ...